You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

//
INSIGHTS

Insights

We provide you with all of the latest legal developments in Southeast Asia, ensuring that you have the up-to-date knowledge you need to navigate the ever-changing legal landscape affecting your business. You can browse our entire library of publications below, and email [email protected] to sign up for updates that are relevant to your interests, delivered straight to your mailbox, as they emerge.

Search Insights

  • Order by
  • Reset

Search Results

0 results found

May 14, 2015
To ensure harmony in regulations between ASEAN countries as well as tighten the management of drug registration, the Ministry of Health (MOH) issued Circular No. 44/2014/TT-BYT dated November 25, 2014, on Registration of Drugs (Circular 44) to replace its previous Circular No. 22/2009/TT-BYT (Circular 22) dated November 24, 2009. Circular 44 took effect on January 15, 2015. Among the contents of Circular 44, there are four main points changed from Circular 22:
May 14, 2015
Patents play a key role in encouraging the development of pharmaceutical products. It can take several hundred million dollars to discover, develop, and gain regulatory approval for a new drug, and funding for research is obtained primarily from profits made while the innovators have exclusive rights to market their medicines. The length of this exclusivity is therefore an important aspect of patent policy for pharmaceuticals.
May 14, 2015
As a developing country with a large population, Vietnam has long viewed parallel imports as an effective antidote to the high price of innovator drugs. The parallel importation of medicines for the prevention and treatment of human diseases is permitted, and even encouraged, under Vietnamese law. Many pharmaceutical manufacturers, however, are understandably concerned that parallel importation could lead to diminished profits, thereby reducing research and development efforts, and leading to a slowdown in the innovation of new drugs.
May 1, 2015
To promote and develop Thailand’s growing insurance industry and prepare for greater market activity under the Asean Economic Community, the government recently amended the laws governing the country’s life and non-life insurance industries for the third time. Formally known as the Life Insurance Act No. 3 of 2015 and the Non-Life Insurance Act No. 3 of 2015, the amendments took effect on March 6, seven years after the previous amendments were made. The changes can be divided into three main parts as follows:
April 30, 2015
In early 2015, Vietnamese authorities continued their stepped-up IP enforcement campaigns, showing a commitment to improve the IPR situation against the backdrop of TPP and EU FTA negotiations. Notable cases included:Trade Name Infringement Precedent
April 30, 2015
Over the past 20 years since its enactment, the Thai Copyright Act B.E. 2537 (A.D. 1994) has remained unchanged, despite numerous attempts by legislators to modernize the law. As a result, Thailand’s copyright law is out of date, and legal measures to combat piracy are inadequate.In late 2014, however, the National Legislative Assembly passed two copyright bills into law. They were published in the Royal Gazette  on February 5, 2015, and will take effect 180 days after publication.